Knowledge, Attitude And Perception Of Ropivacaine Usage In Prosthodontics

Abstract

Introduction The success of a minor oral procedure relies on the efficiency of the local anaesthetic and the dexterity of the operator. Local anaesthetic with an extended duration of action, good analgesia, and negligible toxicity is an optimal choice. A common standard option is 2% lignocaine hydrochloride with adrenaline (1:80,000). However, lignocaine is not recommended for long procedures or in patients with cardiovascular compromise.Various clinical trials have suggested other options, one of which is ropivacaine.The aim of the survey was to assess the knowledge, attitude and practice of ropivacaine in prosthodontics. Materials and methods An online questionnaire based cross-sectional study was conducted during 1st July to 12th July 2021, among undergraduate and postgraduate dental students of Saveetha Dental College. An online questionnaire survey which consisted of 17 questions, was circulated among the dental practitioners (n=100) within the city based on the inclusion and exclusion criteria of the study and the response was subjected to analysis. Results According to the survey 88.89% of the participants are aware that Ropivacaine falls under long acting amide link. According to the survey 55% of the participants think lidocaine is the most commonly used Local anaesthesia followed by ropivacaine 35%. About 92 % of the participants think Ropivacaine is better than bupivacaine due to its less lipophilic and have a significantly higher threshold CNS toxicity. According to the survey 85% of the participants think 14 minutes is the half life of ropivacaine followed by 2mins, 10mins, 4mins. Ropivacaine can be used in long prosthodontics procedures like FPD. According to the survey 58% know the commercial name of ropivacaine whereas 31% don’t know the commercial name. Conclusion: Within the limitations of the study, the participants are aware of ropivacaine.